| Identification | |
| Name: | 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6S,8aS)- |
| Synonyms: | 2-Epigalanthamine(8CI); Epigalanthamine (6CI,7CI); Galanthamine, (3a)-; (-)-Epigalanthamine; 2-epi-Galanthamine;3-Epigalanthamine; 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, [4aS-(4aa,6a,8aR*)]-; SPH 1068 |
| CAS: | 1668-85-5 |
| Molecular Formula: | C17H21 N O3 |
| Molecular Weight: | 287.35 |
| InChI: | InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14+,17+/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 219.5°C |
| Boiling Point: | 439.3°C at 760 mmHg |
| Density: | 1.28g/cm3 |
| Refractive index: | 1.636 |
| Specification: | Off-White Solid usageEng:A selective acetylcholinesterase inhibitor. |
| Flash Point: | 219.5°C |
| Usage: | A selective acetylcholinesterase inhibitor. |
| Safety Data | |
 |
|
